lenacapavir
Why the medical community is thrilled by U.S. support for a ‘breakthrough’ HIV drug
Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of effort will be a model for how it does global health work in the future.
HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?
